BR9104948A - Compostos,processo para a sua producao,agente farmaceutico e processo para a sua producao - Google Patents
Compostos,processo para a sua producao,agente farmaceutico e processo para a sua producaoInfo
- Publication number
- BR9104948A BR9104948A BR919104948A BR9104948A BR9104948A BR 9104948 A BR9104948 A BR 9104948A BR 919104948 A BR919104948 A BR 919104948A BR 9104948 A BR9104948 A BR 9104948A BR 9104948 A BR9104948 A BR 9104948A
- Authority
- BR
- Brazil
- Prior art keywords
- production
- compounds
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4036645A DE4036645A1 (de) | 1990-11-16 | 1990-11-16 | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9104948A true BR9104948A (pt) | 1992-06-23 |
Family
ID=6418438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR919104948A BR9104948A (pt) | 1990-11-16 | 1991-11-14 | Compostos,processo para a sua producao,agente farmaceutico e processo para a sua producao |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0485929A1 (pt) |
| JP (1) | JPH04283569A (pt) |
| KR (1) | KR920009802A (pt) |
| CN (1) | CN1061410A (pt) |
| AU (1) | AU8785591A (pt) |
| BR (1) | BR9104948A (pt) |
| CA (1) | CA2055636A1 (pt) |
| CS (1) | CS347091A3 (pt) |
| DE (1) | DE4036645A1 (pt) |
| FI (1) | FI915381A (pt) |
| HU (1) | HUT59673A (pt) |
| IE (1) | IE913991A1 (pt) |
| IL (1) | IL100058A0 (pt) |
| MX (1) | MX9102098A (pt) |
| NO (1) | NO914481L (pt) |
| PT (1) | PT99521A (pt) |
| ZA (1) | ZA919059B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4036706A1 (de) * | 1990-11-17 | 1992-05-21 | Hoechst Ag | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| DE4200954A1 (de) * | 1991-04-26 | 1992-10-29 | Bayer Ag | Heterocyclisch substituierte phenylessigsaeurederivate |
| DE4309968A1 (de) * | 1993-03-26 | 1994-09-29 | Bayer Ag | Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten |
| CZ283315B6 (cs) * | 1992-12-17 | 1998-02-18 | Sankyo Company Limited | Bifenylové deriváty, způsob výroby a farmaceutické prostředky k léčení hypertense a srdečních onemocnění, které tyto deriváty obsahují |
| US5300668A (en) * | 1993-03-10 | 1994-04-05 | Pfizer Inc. | Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| PE20070182A1 (es) | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
| PE20070404A1 (es) | 2005-07-29 | 2007-05-10 | Wyeth Corp | Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| US20240336638A1 (en) * | 2021-07-01 | 2024-10-10 | Guoqin ZHUGE | Imidazole compound, and intermediate and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1329614C (en) * | 1987-05-02 | 1994-05-17 | Rainer Buerstinghaus | N-substituted azoles |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
-
1990
- 1990-11-16 DE DE4036645A patent/DE4036645A1/de not_active Withdrawn
-
1991
- 1991-11-11 EP EP91119186A patent/EP0485929A1/de not_active Withdrawn
- 1991-11-14 BR BR919104948A patent/BR9104948A/pt unknown
- 1991-11-14 FI FI915381A patent/FI915381A/fi unknown
- 1991-11-14 IL IL100058A patent/IL100058A0/xx unknown
- 1991-11-15 JP JP3326662A patent/JPH04283569A/ja active Pending
- 1991-11-15 KR KR1019910020341A patent/KR920009802A/ko not_active Application Discontinuation
- 1991-11-15 ZA ZA919059A patent/ZA919059B/xx unknown
- 1991-11-15 PT PT99521A patent/PT99521A/pt not_active Application Discontinuation
- 1991-11-15 CA CA002055636A patent/CA2055636A1/en not_active Abandoned
- 1991-11-15 AU AU87855/91A patent/AU8785591A/en not_active Abandoned
- 1991-11-15 IE IE399191A patent/IE913991A1/en not_active Application Discontinuation
- 1991-11-15 CS CS913470A patent/CS347091A3/cs unknown
- 1991-11-15 CN CN91110736A patent/CN1061410A/zh active Pending
- 1991-11-15 NO NO91914481A patent/NO914481L/no unknown
- 1991-11-15 MX MX9102098A patent/MX9102098A/es unknown
- 1991-11-15 HU HU913583A patent/HUT59673A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU8785591A (en) | 1992-05-21 |
| CA2055636A1 (en) | 1992-05-17 |
| KR920009802A (ko) | 1992-06-25 |
| IL100058A0 (en) | 1992-08-18 |
| HUT59673A (en) | 1992-06-29 |
| IE913991A1 (en) | 1992-05-20 |
| NO914481D0 (no) | 1991-11-15 |
| NO914481L (no) | 1992-05-18 |
| ZA919059B (en) | 1992-07-29 |
| FI915381A0 (fi) | 1991-11-14 |
| JPH04283569A (ja) | 1992-10-08 |
| MX9102098A (es) | 1992-07-08 |
| HU913583D0 (en) | 1992-01-28 |
| DE4036645A1 (de) | 1992-05-21 |
| FI915381A (fi) | 1992-05-17 |
| PT99521A (pt) | 1992-09-30 |
| CN1061410A (zh) | 1992-05-27 |
| CS347091A3 (en) | 1992-06-17 |
| EP0485929A1 (de) | 1992-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9104948A (pt) | Compostos,processo para a sua producao,agente farmaceutico e processo para a sua producao | |
| BR9707839A (pt) | Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação | |
| BR9200951A (pt) | Compostos, processo para sua producao,preparacoes farmaceuticas e uso | |
| BR9503638A (pt) | Composto processo para sua produção e formulação farmacêutica | |
| BR9103550A (pt) | Amido 3-pirazol,processo para sua fabricacao e composicao farmaceutica | |
| BR9408463A (pt) | Novos derivados de ginkgolide e processo para sua preparação | |
| BR9000116A (pt) | Alfa-diazo-beta-cetoester polifuncional,processo para sua preparacao e sua utilizacao | |
| BR8801674A (pt) | 1-(2-cloro-tiazol-5-il-metil)-2-nitro-imino-1,3-diazacicloalcanos 3-substituidos,processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para a preparacao de composicoes | |
| BR9206785A (pt) | Bolsa para sangue e processo para sua produção | |
| BR9101121A (pt) | Composto,processo para sua preparacao,suas aplicacoes,e preparado farmaceutico | |
| BR9601275A (pt) | Compostos processo para sua preparação medicamentos preparação farmacêutica processo para sua produção e uso | |
| BR9103036A (pt) | Composto,formulacao farmaceutica e processo para a preparacao do composto | |
| BR9202325A (pt) | Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao | |
| BR9303456A (pt) | Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego | |
| BR9101488A (pt) | Preparados de lipossomas,sua utilizacao e processo para a sua producao | |
| BR9200333A (pt) | Pistao e processo para sua fabricacao | |
| BR9004194A (pt) | Poliisocianatos,misturas,processo para sua preparacao e emprego | |
| BR9305161A (pt) | Composto, composição farmacêutica e processo para a preparação do composto | |
| BR9602337A (pt) | Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento | |
| PT1015433E (pt) | 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos | |
| BR9006224A (pt) | Derivados de piridinil-pirimidina,processo para sua preparacao,pesticidas,utilizacao,processos para o combate a parasitas e para a preparacao de pesticidas | |
| BR8901404A (pt) | Benzotiazolonas 3,7-dissubstituidas,processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para a preparacao de composicoes | |
| BR8803371A (pt) | Composto pesticida,processo para sua producao e agente pesticida | |
| BR9505899A (pt) | Tienopiridonas processo para sua preparação processo para a produção farmacêutica preparação farmacêutica e uso | |
| BR9611010A (pt) | Processo para preparação de medicamento antimalária |